Up 152% in December, Is uniQure a Good Stock to Buy Now and Hold Through 2025? [Yahoo! Finance]
uniQure N.V. - Ordinary Shares (QURE)
Last uniqure n.v. - ordinary shares earnings: 4/29 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
uniqure.com/investors-newsroom/overview.php
Company Research
Source: Yahoo! Finance
Sales estimates for AMT-130 suggest more than $1 billion annually at its peak, as Huntington's disease is an inherited disorder that affects around 70,000 people in the U.S. and Europe, with no approved drugs that slow the progression of the disease. Was this helpful? Yes No Is uniQure's stock a good buy now and hold through 2025? Buying uniQure's stock now to hold at least a few years could be a smart bet, but only for folks with an extremely high risk tolerance, as the company's market cap could increase more than tenfold if AMT-130 earns FDA approval and goes on to generate more than $1 billion in annual sales. Was this helpful? Yes No Is uniQure's financial situation stable enough to support its development plans? uniQure finished September with $435 million in cash after burning through $44.4 million in the third quarter, which is enough to last the company for at least a couple of years without needing to ask for more capital. Was this helpful? Yes No
Show less
Read more
Impact Snapshot
Event Time:
QURE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QURE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QURE alerts
High impacting uniQure N.V. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
QURE
News
- uniQure (NASDAQ: QURE) had its price target raised by analysts at Mizuho from $7.00 to $20.00. They now have a "neutral" rating on the stock.MarketBeat
- uniQure (NASDAQ: QURE) had its price target raised by analysts at Stifel Nicolaus from $12.00 to $32.00. They now have a "buy" rating on the stock.MarketBeat
- uniQure (NASDAQ: QURE) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $9.00 to $20.00. They now have a "neutral" rating on the stock.MarketBeat
- uniQure (NASDAQ: QURE) was upgraded by analysts at Wells Fargo & Company from a "hold" rating to a "strong-buy" rating.MarketBeat
- uniQure (NASDAQ: QURE) had its price target raised by analysts at Leerink Partners from $26.00 to $44.00. They now have an "outperform" rating on the stock.MarketBeat
QURE
Earnings
- 11/5/24 - Beat
QURE
Sec Filings
- 12/17/24 - Form SCHEDULE
- 12/12/24 - Form 4
- 12/10/24 - Form 4
- QURE's page on the SEC website